undamentalytics Newsletter

Capsovision, Inc income statement

In fiscal 2025, Capsovision, Inc reported revenue of $13.6m, up 15.3% on the year before, operating income of −$25.5m (a -188.3% margin) and net income of −$25.3m, or −$1.03 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Capsovision, Inc: income statement, annual
Fiscal year2024Dec 20242025Dec 2025LTMJun 2026
Revenue121414
Cost of revenue567
Gross profit677
Research and development151822
Selling and marketing788
General and administrative478
Operating income−20−26−30
Income before tax−20−25−30
Income tax000
Net income−20−25−30
Diluted EPS−$9.85−$1.03—
Diluted shares (average)2m25m—
EBITDA−20−25−30

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: CV vs NNOXCV vs MDAICV vs HSDT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Capsovision, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Capsovision, Inc.